全文获取类型
收费全文 | 534408篇 |
免费 | 34178篇 |
国内免费 | 705篇 |
专业分类
耳鼻咽喉 | 7022篇 |
儿科学 | 17163篇 |
妇产科学 | 13748篇 |
基础医学 | 87340篇 |
口腔科学 | 15045篇 |
临床医学 | 45629篇 |
内科学 | 98497篇 |
皮肤病学 | 12500篇 |
神经病学 | 37744篇 |
特种医学 | 19472篇 |
外国民族医学 | 63篇 |
外科学 | 80706篇 |
综合类 | 8565篇 |
一般理论 | 119篇 |
预防医学 | 39700篇 |
眼科学 | 12660篇 |
药学 | 42022篇 |
中国医学 | 1030篇 |
肿瘤学 | 30266篇 |
出版年
2018年 | 5262篇 |
2016年 | 4396篇 |
2015年 | 4832篇 |
2014年 | 6463篇 |
2013年 | 10109篇 |
2012年 | 13754篇 |
2011年 | 15273篇 |
2010年 | 8868篇 |
2009年 | 8258篇 |
2008年 | 14581篇 |
2007年 | 15692篇 |
2006年 | 15980篇 |
2005年 | 15336篇 |
2004年 | 15009篇 |
2003年 | 14227篇 |
2002年 | 14136篇 |
2001年 | 24877篇 |
2000年 | 25914篇 |
1999年 | 21264篇 |
1998年 | 5699篇 |
1997年 | 4909篇 |
1996年 | 5255篇 |
1995年 | 4765篇 |
1994年 | 4463篇 |
1992年 | 16209篇 |
1991年 | 16752篇 |
1990年 | 16857篇 |
1989年 | 16235篇 |
1988年 | 14943篇 |
1987年 | 14796篇 |
1986年 | 13971篇 |
1985年 | 13330篇 |
1984年 | 9833篇 |
1983年 | 8417篇 |
1982年 | 4638篇 |
1981年 | 4300篇 |
1979年 | 9578篇 |
1978年 | 6957篇 |
1977年 | 5857篇 |
1976年 | 5663篇 |
1975年 | 6478篇 |
1974年 | 7709篇 |
1973年 | 7213篇 |
1972年 | 7041篇 |
1971年 | 6766篇 |
1970年 | 6278篇 |
1969年 | 5972篇 |
1968年 | 5638篇 |
1967年 | 5071篇 |
1966年 | 4514篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Akira Sawaki Nobumasa Mizuno Kuniyuki Takahashi Tsuneya Nakamura Masahiro Tajika Hiroki Kawai Toshifumi Isaka Hiroshi Imaoka Yasuyuki Okamoto Masatoshi Aoki Hiroyuki Inoue Ahmed AS Salem Yasushi Yatabe Kenji Yamao 《Digestive endoscopy》2006,18(1):40-44
Background: Gastrointestinal stromal tumors (GIST) are one of the most common mesenchymal tumors of the gastrointestinal tract. GIST are defined by positive immunohistochemical staining for KIT or CD34 and thus are generally diagnosed after surgery. Because small GIST are rarely diagnosed before surgery, the clinical course of these small tumors is not clear. The aim of the present study was to follow changes in size and configuration of small GIST that were pathologically confirmed using endoscopic ultrasonography‐guided fine‐needle aspiration biopsy (EUS‐FNAB). Methods: Between July 1997 and December 2003, 16 tumors in 16 patients (10 men and 6 women) with an immunohistochemical diagnosis of GIST were regularly followed in our hospital. The median patient age when EUS‐FNAB was performed was 62 years (range 26–82 years) and the median follow‐up period was 4.9 years (range 0.5–9.6 years). Results: Fourteen tumors showed no remarkable changes in size and shape during follow up compared with the initial diagnosis. Two tumors enlarged: one tumor approximately doubled its diameter in 8 years and the other tumor increased from 1.8 cm at diagnosis to up to 10 cm after only 2 years. Doubling time of the latter tumor was calculated as 3.1 months. Conclusions: We conclude that EUS‐FNAB might be a good modality for final diagnosis of GIST without surgery, and that GIST without rapid growth on follow up can be endoscopically followed. 相似文献
72.
73.
Published data devoted to making and characterization of the properties of polymeric wound dressings with proteolytic action
are reviewed. These data are indicative of individual dependence of the physicochemical properties, activity, and stability
of each particular enzyme on the type of polymer matrix and the method of immobilization. In order to obtain wound dressings,
which are active in physiological medium and retain their activity upon sterilization, it is necessary to optimize the composition
and characteristics of a polymer matrix and the enzyme included into its structure.
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 40, No. 8, pp. 24–28, August, 2006. 相似文献
74.
R H Green C E Brightling S McKenna B Hargadon N Neale D Parker C Ruse I P Hall I D Pavord 《The European respiratory journal》2006,27(6):1144-1151
There is increasing evidence that the assessment of eosinophilic airway inflammation using induced sputum and measurement of airway hyperresponsiveness provides additional, clinically important information concerning asthma control. The aim of this study was to directly compare the effects of different treatments on these markers in patients with asthma and persistent symptoms, despite the use of low-dose inhaled corticosteroids. A double-blind four-way crossover study was performed, which compared a 1-month treatment with budesonide 400 mug b.i.d., additional formoterol, additional montelukast and placebo in 49 patients with uncontrolled asthma despite budesonide 100 mug b.i.d., with each treatment separated by a 4-week washout period. The change in sputum eosinophil count with formoterol (2.4 to 3.8% change, 0.6-fold reduction, 95% confidence interval (CI) 0.5-0.9) differed significantly from placebo (2.8 to 2.5% change, 1.1-fold reduction, 95% CI 0.7-1.6) and high-dose budesonide (2.7 to 1.6% change, 1.6-fold reduction, 95% CI 1.2-2.2). The effects of montelukast did not differ from placebo. The changes in methacholine airway responsiveness were small and did not differ between treatments. High-dose budesonide had the broadest range of beneficial effects on other outcomes, including symptom scores, morning peak expiratory flow and forced expiratory volume in one second. In conclusion, treatment given in addition to low-dose inhaled corticosteroids results in modest benefits. Formoterol and high-dose budesonide have contrasting effects on eosinophilic airway inflammation. 相似文献
75.
J Müller-Quernheim K I Gaede E Fireman G Zissel 《The European respiratory journal》2006,27(6):1190-1195
An increase in chronic beryllium disease (CBD) has been suggested due to higher industrial use of beryllium alloys. Since occupational CBD is a perfect phenocopy of sarcoidosis, it might be misdiagnosed as sarcoidosis. In the current it was hypothesised that CBD exists in cohorts of sarcoidosis patients. In a prospective case study, sarcoidosis patients were evaluated for potential beryllium exposure. In those patients in whom beryllium exposure was confirmed and beryllium hypersensitivity demonstrated, the diagnosis of sarcoidosis was rejected and corrected to CBD. In 84 patients seen for re-evaluation or making a diagnosis of sarcoidosis, beryllium exposure was recognised and a diagnosis of CBD was made in 34 out of 84 patients. The time lag between clinical diagnosis of sarcoidosis and the final diagnosis of CBD ranged 0-18 yrs (median 3 yrs) and the mean (range) age at time of diagnosis of CBD was 43.9(25-80) yrs. Beryllium-contaminated workplaces causing disease encompassed a wide spectrum of industries and technical trades in which beryllium-exposure is generally not perceived as a health hazard. In conclusion, chronic beryllium disease still belongs to the spectrum of differential diagnoses of granulomatous disorders. 相似文献
76.
77.
78.
Severe adverse effects during the use of ovulation inhibitors occur mostly in women who have an elevated risk for the development of certain diseases owing to hereditary or acquired factors. By means of a careful personal or family history analysis as well as specific laboratory examinations, an existing predisposition may frequently be diagnosed and the individual risk associated with the use of oral contraceptive inhibitors may be estimated. The present contribution describes the potential effects of treatment with ovulation inhibitors on women with thrombophilia, cardiovascular disease, diabetes mellitus, dyslipidemia, overweight or underweight, tumors, psychiatric and neurological diseases and autoimmune disease. The hormonal methods and non-hormonal alternatives available for contraception are elucidated according to existing lesions and risk factors and the advantages and disadvantages are discussed. 相似文献
79.
80.